To investigate whether activation of LRP5 could enhance the tumorigenic ability of CRC cells in vivo, nude mice were subcutaneously injected with LRP5‐ACT or NC‐ACT HCT‐116 cells respectively. This evidence concerns the gene LRP5 and colorectal carcinoma.